Stephanie Anne Lee-Felker

Title(s)HS Associate Clinical Professor, Radiological Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI. Eur Radiol. 2024 Oct; 34(10):6358-6368. Yan R, Murakami W, Mortazavi S, Yu T, Chu FI, Lee-Felker S, Sung K. PMID: 38683385; PMCID: PMC11399191.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Clinical Significance of Background Parenchymal Enhancement in Breast Cancer Risk Stratification. J Magn Reson Imaging. 2024 05; 59(5):1742-1757. Murakami W, Mortazavi S, Yu T, Kathuria-Prakash N, Yan R, Fischer C, McCann KE, Lee-Felker S, Sung K. PMID: 37724902.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Ensemble Learning for Breast Cancer Lesion Classification: A Pilot Validation Using Correlated Spectroscopic Imaging and Diffusion-Weighted Imaging. Metabolites. 2023 Jul 11; 13(7). Joy A, Lin M, Joines M, Saucedo A, Lee-Felker S, Baker J, Chien A, Emir U, Macey PM, Thomas MA. PMID: 37512542; PMCID: PMC10385820.
      View in: PubMed   Mentions:
    4. Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: acceleration and compressed sensing reconstruction. BJR Open. 2022; 4(1):20220009. Joy A, Saucedo A, Joines M, Lee-Felker S, Kumar S, Sarma MK, Sayre J, DiNome M, Thomas MA. PMID: 36860693; PMCID: PMC9969076.
      View in: PubMed   Mentions: 3  
    5. Quantitative Analysis of Contrast-enhanced Mammography for Risk Stratification of Benign Versus Malignant Disease and Molecular Subtype. J Breast Imaging. 2022 Oct 10; 4(5):496-505. Cain N, Rahbar G, Park E, Tang M, Andrews-Tang D, Gupta E, Roth A, Lee-Felker S, Thomas M. PMID: 38416945.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Quantitative Predictors of Response to Neoadjuvant Chemotherapy on Dynamic Contrast-enhanced 3T Breast MRI. J Breast Imaging. 2022 Apr 15; 4(2):168-176. Murakami W, Won Choi H, Joines MM, Hoyt A, Doepke L, McCann KE, Salamon N, Sayre J, Lee-Felker S. PMID: 38422427.
      View in: PubMed   Mentions: 1     Fields:    
    7. 68Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation. Eur J Nucl Med Mol Imaging. 2021 03; 48(3):924-926. Sonni I, Lee-Felker S, Memarzadeh S, Quinn MM, Mona CE, Lückerath K, Czernin J, Calais J. PMID: 32651662.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    8. Abbreviated Breast MRI for Estimating Extent of Disease in Newly Diagnosed Breast Cancer. J Breast Imaging. 2020 Feb 04; 2(1):43-49. Lee-Felker S, Joines M, Storer L, Li B, DeBruhl N, Sayre J, Hoyt A. PMID: 38424993.
      View in: PubMed   Mentions: 4     Fields:    
    9. Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases. Clin Breast Cancer. 2019 02; 19(1):e142-e151. Hsu W, Zhou X, Petruse A, Chau N, Lee-Felker S, Hoyt A, Wenger N, Elashoff D, Naeim A. PMID: 30366654.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    10. Accuracy of whole-body HDP SPECT/CT, FDG PET/CT, and their combination for detecting bone metastases in breast cancer: an intra-personal comparison. Am J Nucl Med Mol Imaging. 2018; 8(3):159-168. Rager O, Lee-Felker SA, Tabouret-Viaud C, Felker ER, Poncet A, Amzalag G, Garibotto V, Zaidi H, Walter MA. PMID: 30042868; PMCID: PMC6056244.
      View in: PubMed   Mentions: 11  
    11. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):733-734. Lee-Felker S. PMID: 29437529.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup. Biomed Res Int. 2017; 2017:7039406. Rager O, Nkoulou R, Exquis N, Garibotto V, Tabouret-Viaud C, Zaidi H, Amzalag G, Lee-Felker SA, Zilli T, Ratib O. PMID: 28812019; PMCID: PMC5546128.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    13. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease. Radiology. 2017 11; 285(2):389-400. Lee-Felker SA, Tekchandani L, Thomas M, Gupta E, Andrews-Tang D, Roth A, Sayre J, Rahbar G. PMID: 28654337.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    14. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer. Abdom Radiol (NY). 2016 05; 41(5):954-62. Felker ER, Lee-Felker SA, Feller J, Margolis DJ, Lu DS, Princenthal R, May S, Cohen M, Huang J, Yoshida J, Greenwood B, Kim HJ, Raman SS. PMID: 27118268.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    15. Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy. Clin Radiol. 2016 Jun; 71(6):618.e1-7. Lee-Felker SA, Thomas M, Felker ER, Traina M, Salih M, Hernandez S, Bradfield J, Lee M, Meymandi S. PMID: 27017480.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis. AJR Am J Roentgenol. 2015 Jul; 205(1):2-9. Lee-Felker SA, Felker ER, Kadell B, Farrell J, Raman SS, Sayre J, Lu DS. PMID: 26102377.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Intraductal Cooling via a Nasobiliary Tube During Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries. AJR Am J Roentgenol. 2015 Jun; 204(6):1329-35. Felker ER, Lee-Felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS. PMID: 26001245.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol. 2014 Nov; 203(5):W516-24. Lee-Felker SA, Felker ER, Tan N, Margolis DJ, Young JR, Sayre J, Raman SS. PMID: 25341166.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    19. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses. AJR Am J Roentgenol. 2013 Nov; 201(5):1029-35. Felker ER, Lee-Felker SA, Alpern L, Lu D, Raman SS. PMID: 24147473.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings. AJR Am J Roentgenol. 2012 Jan; 198(1):W20-6. Hindman NM, Bosniak MA, Rosenkrantz AB, Lee-Felker S, Melamed J. PMID: 22194510.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans